(Q46313485)

21 December 2017

title

Use of a direct thrombin inhibitor (argatroban) during pulse-spray thrombolysis in experimental thrombosis (English)

1 reference

21 December 2017

0 references

1 reference

K Valji

1

1 reference

21 December 2017

K Arun

series ordinal

2

1 reference

21 December 2017

J J Bookstein

series ordinal

3

1 reference

21 December 2017

publication date

1 January 1995

1 reference

21 December 2017

Journal of Vascular and Interventional Radiology

published in

1 reference

21 December 2017

volume

6

1 reference

21 December 2017

issue

1

1 reference

21 December 2017

page(s)

91-95

1 reference

21 December 2017

Adjuvant antiplatelet strategies in coronary thrombolysis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971067-3

7 January 2021

Antiplatelet and anticoagulant therapy during coronary thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971067-3

7 January 2021

Relative efficacy of antithrombin compared with antiplatelet agents in accelerating coronary thrombolysis and preventing early reocclusion

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971067-3

7 January 2021

Intracoronary prostaglandin E1 plus streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971067-3

7 January 2021

Pulsed-spray thrombolysis of arterial and bypass graft occlusions

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971067-3

7 January 2021

Efficacy of adjunctive intrathrombic heparin with pulse spray thrombolysis in rabbit inferior vena cava thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971067-3

7 January 2021

Effects of intrathrombic administration of prostaglandin E1 during pulse-spray thrombolysis with tissue-type plasminogen activator in experimental thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971067-3

7 January 2021

In vivo thrombin inhibition enhances and sustains arterial recanalization with recombinant tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971067-3

7 January 2021

Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine prepa

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971067-3

7 January 2021

Protection of factor Xa from neutralization by the heparin-antithrombin complex

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971067-3

7 January 2021

The multiple complexes formed by the interaction of platelet factor 4 with heparin

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971067-3

7 January 2021

Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971067-3

7 January 2021

Thrombin inhibitors in unstable angina: rebound or continuation of angina after argatroban withdrawal?

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971067-3

7 January 2021

Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971067-3

7 January 2021

Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971067-3

7 January 2021

Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971067-3

7 January 2021

Anticoagulant therapy with MD805 of a hemodialysis patient with heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971067-3

7 January 2021

Anticoagulation with a synthetic thrombin inhibitor after cardiovascular surgery and for treatment of disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971067-3

7 January 2021

Initial experience with a direct antithrombin, Hirulog, in unstable angina. Anticoagulant, antithrombotic, and clinical effects

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2971067-3

7 January 2021

10.1016/S1051-0443(95)71067-3

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017